160 related articles for article (PubMed ID: 6432730)
1. Effect of spironolactone on testosterone and LHRH responsiveness in women with polycystic ovarian disease.
Evron S; Yosef SM; Schenker JG; Diamant YZ
Isr J Med Sci; 1984 Jul; 20(7):630-3. PubMed ID: 6432730
[No Abstract] [Full Text] [Related]
2. The effects of buserelin on the hormonal states in PCOD.
Willemsen WN; Franssen AM; Rolland R; Vemer HM
Prog Clin Biol Res; 1986; 225():377-89. PubMed ID: 3097673
[No Abstract] [Full Text] [Related]
3. Hyperprolactinaemia in polycystic ovary syndrome.
Lunde O
Ann Chir Gynaecol; 1981; 70(4):197-201. PubMed ID: 6797343
[TBL] [Abstract][Full Text] [Related]
4. Hirsutism--a low dose spironolactone therapy.
Vĕtr M
Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
[TBL] [Abstract][Full Text] [Related]
5. Low dose spironolactone in the treatment of female hyperandrogenemia and hirsutism.
Vĕtr M; Sobek A
Acta Univ Palacki Olomuc Fac Med; 1993; 135():55-7. PubMed ID: 7976677
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
7. Hormonal correlations in the polycystic ovary syndrome.
Messina M; Milani P; Gentile L
Boll Soc Ital Biol Sper; 1986 Jan; 62(1):31-5. PubMed ID: 3087390
[No Abstract] [Full Text] [Related]
8. [Comparison between purified FSH and hMG for induction of ovulation in women with PCO syndrome].
Uemura T; Yoshimura Y; Ishikawa M; Asukai K; Minaguchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):923-6. PubMed ID: 2507714
[No Abstract] [Full Text] [Related]
9. Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary.
Venturoli S; Paradisi R; Fabbri R; Magrini O; Porcu E; Flamigni C
Obstet Gynecol; 1984 Jan; 63(1):6-11. PubMed ID: 6419189
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
Filicori M; Flamigni C; Campaniello E; Meriggiola MC; Michelacci L; Valdiserri A; Ferrari P
Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of spironolactone in polycystic ovary syndrome.
Milewicz A; Silber D; Kirschner MA
Obstet Gynecol; 1983 Apr; 61(4):429-32. PubMed ID: 6828272
[TBL] [Abstract][Full Text] [Related]
12. Primary amenorrhoea associated with polycystic ovarian syndrome.
Valkov IM; Dokumov SI
Reproduccion; 1981; 5(2):119-26. PubMed ID: 6790313
[TBL] [Abstract][Full Text] [Related]
13. Luteinizing hormone, adrenal androgenesis, and polycystic ovarian disease.
Polansky S
Obstet Gynecol; 1975 Apr; 45(4):451-4. PubMed ID: 1121374
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the hypothalamic origin of the polycystic ovary syndrome.
Wortsman J; Singh KB; Murphy J
Obstet Gynecol; 1981 Aug; 58(2):137-41. PubMed ID: 6454866
[TBL] [Abstract][Full Text] [Related]
15. Testosterone, 17 Ks, 17 beta E2 FSH-LH variations and hirsutism modifications during spironolactone therapy.
Spandri P; Gangemi M; Nardelli GB; Meneghetti G; Grandesso R; De Salvia D; Ambrosio GB; Predebon O
Clin Exp Obstet Gynecol; 1984; 11(1-2):49-54. PubMed ID: 6424970
[TBL] [Abstract][Full Text] [Related]
16. Serum gonadotropin levels and ancillary studies in Stein-Leventhal syndrome treated with clomiphene citrate.
Gambrell RD; Greenblatt RB; Mahesh VB
Obstet Gynecol; 1971 Dec; 38(6):850-62. PubMed ID: 5125433
[No Abstract] [Full Text] [Related]
17. Proceedings: Effect of active immunization against oestradiol-6-bovine serum albumin on circulating levels of oestradiol, testosterone, luteinizing hormone, follicle-stimulating hormone, prolactin and anti-oestradiol tire in the male rat.
Hillier SG; Groom GV; Boyns AR; Cameron EH
J Endocrinol; 1974 May; 61(2):LI-LII. PubMed ID: 4462605
[No Abstract] [Full Text] [Related]
18. Combined use of gonadotropin-releasing hormone and its analogues for ovulation induction optimization.
Filicori M
Clin Obstet Gynecol; 1993 Sep; 36(3):737-43. PubMed ID: 8403620
[No Abstract] [Full Text] [Related]
19. [Stein-Leventhal syndrome. Personal cases].
Rapino P; Sabatino P; Della Lunga S; Marulli R
Minerva Med; 1982 Oct; 73(40):2793-800. PubMed ID: 6813772
[No Abstract] [Full Text] [Related]
20. Adjusting the dose to the individual response of the patient during the induction of ovulation with pulsatile gonadotropin-releasing hormone.
Mais V; Melis GB; Strigini F; Antinori D; de Ruggiero A; Fioretti P
Fertil Steril; 1991 Jan; 55(1):80-5. PubMed ID: 1898894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
